Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status.

Connors, Jean M; Ridker, Paul M

Connors, Jean M; Ridker, Paul M.

Connors JM; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts.
Ridker PM; Divisions of Cardiovascular Medicine, and Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

JAMA ; 327(13): 1234-1235, 2022 04 05.

Article in English | MEDLINE | ID: covidwho-1801954

Subject(s)

COVID-19; Fibrinolytic Agents; Thromboinflammation; COVID-19/complications; Fibrinolytic Agents/therapeutic use; Humans; Inflammation/drug therapy; Inflammation/etiology; Thromboinflammation/drug therapy; Thromboinflammation/etiology; Thrombosis/etiology; Thrombosis/prevention & control; Thrombosis/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fibrinolytic Agents / COVID-19 / Thromboinflammation Topics: Long Covid Limits: Humans Language: English Journal: JAMA Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google